Policy ForumSCIENCE AND REGULATION

Influence, integrity, and the FDA: An ethical framework

See allHide authors and affiliations

Science  01 Sep 2017:
Vol. 357, Issue 6354, pp. 876-877
DOI: 10.1126/science.aao1056

Article Information

vol. 357 no. 6354 876-877

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • .

Author Information

  1. Spencer Phillips Hey1,2,
  2. I. Glenn Cohen3,
  3. Eli Y. Adashi4,
  4. Aaron S. Kesselheim1,2
  1. 1Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
  2. 2Center for Bioethics, Harvard Medical School, Boston, MA 02115, USA.
  3. 3Petrie-Flom Center, Harvard Law School, Cambridge, MA 02138, USA.
  4. 4Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
  1. Email: akesselheim{at}bwh.harvard.edu

Altmetric

Article usage

Article usage: August 2017 to September 2020

AbstractFullPdf
Aug 2017181210693
Sep 201710108364450
Oct 20173674761
Nov 20172261725
Dec 2017169524
Jan 20181181519
Feb 20181062616
Mar 2018902125
Apr 20181041916
May 2018891610
Jun 201879610
Jul 20187468
Aug 201859912
Sep 2018821717
Oct 2018931911
Nov 2018882310
Dec 201810158
Jan 201949107
Feb 2019772128
Mar 201943115
Apr 201961157
May 2019511312
Jun 20193956
Jul 20192964
Aug 20192943
Sep 20192751
Oct 201938167
Nov 20193698
Dec 20194810
Jan 20204061
Feb 20202754
Mar 20205767
Apr 202045124
May 20203458
Jun 20202644
Jul 20202243
Aug 20202502
Sep 20201544

Stay Connected to Science